Clinical impact of an interdisciplinary patient safety program for managing drug-related problems in a long-term care hospital
Background Medication reviews intended to identify drug-related problems (DRPs) have been researched in primary care, acute care and nursing homes rather than in long-term care hospitals (LTCHs). Objectives To assess the clinical impact of an interdisciplinary pharmacotherapy quality improvement and patient safety program in elderly patients with polypharmacy admitted to an LTCH. Setting An interventional, longitudinal, prospective study was conducted in a Spanish LTCH Method A total of 162 elderly (≥ 70 years) patients with polypharmacy (≥ 5 medications) were included. Pharmacist conducted the pharmacotherapy follow-up of patients (reconciliation, pharmacotherapeutic optimization, educational interviews) from admission to discharge. Demographic, clinical and treatment-related variables were recorded. Main outcome measured Clinical impact of the program by DRP-based effectiveness and drug-related morbidity (DRM)-based safety indicators. Results 895 DRPs (median of 5 (1–23)) were identified in 153 (94.4%) patients. The most common DRPs were unnecessary drug (25.3%), dosage too high (24.9%) and a need for additional drug (24.8%). The most frequent pharmacotherapy recommendations were individualizing the dosage regimen (29.6%) and stopping (27.3%) or starting (21.9%) a drug. The mean implementation rate of pharmacotherapy recommendations was 90.9%. The effectiveness indicator revealed a 94.9% of prevented or resolved DRPs. The safety indicator showed an 89.3% of prevented or resolved DRM. Therefore, the program prevented or resolved 92.5% of adverse effects and 91.7% of suboptimal responses or therapeutic failures. Conclusion This interdisciplinary patient safety program seems to be a valuable approach to identify, prevent and resolve the high number of DRPs and potential DRM that elderly patients with polypharmacy admitted to an LTCH present.
KeywordsDrug-related problem Elderly Interdisciplinary care Long-term care Pharmacotherapy Quality improvement Patient safety Spain
The authors would like to thank MD PhD Jose Luis Górriz for his suggestions for the preparation of the manuscript.
Conflicts of interest
The authors have no conflicts of interest to declare.
- 1.The European Commission series. The 2015 Ageing Report: Underlying Assumptions and Projection Methodologies. European Commission. 2014. http://ec.europa.eu/economy_finance/publications/european_economy/2014/pdf/ee8_en.pdf. Accessed 23 Sept 2017.
- 9.Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, Pharmaceutical care of the Elderly in Europe Research (PEER) Group, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18(1):63–77.CrossRefPubMedGoogle Scholar
- 13.Pharmaceutical Care Network Europe (PCNE) Foundation. The PCNE classification for drug related problems V 8.01. PCNE Foundation. 2017. http://www.pcne.org/upload/files/215_PCNE_classification_V8-01.pdf. Accessed 23 Sept 2017.
- 14.Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician’s guide. 3rd ed. New York: The McGraw-Hill Companies, Inc; 2004.Google Scholar
- 20.Climente Martí M, Jiménez Torres N. Manual for pharmaceutical care. 3rd ed. Valencia: AFAHPE. Dr. Peset University Hospital; 2005.Google Scholar
- 22.National Transitions of Care Coalition. Improving transitions of care. The vision of the National Transitions of Care Coalition. 2008. http://www.ntocc.org/Portals/0/PDF/Resources/PolicyPaper.pdf. Accessed 23 Sept 2017.
- 23.American Pharmacists Association, American Society of Health-System Pharmacists. Improving care transitions: optimizing medication reconciliation. 2012. https://www.pharmacist.com/sites/default/files/files/2012_improving_care_transitions.pdf. Accessed 23 Sept 2017.
- 34.da Costa FA, Silvestre L, Periquito C, Carneiro C, Oliveira P, Fernandes AI, et al. Drug-related problems identified in a sample of portuguese institutionalised elderly patients and pharmacists’ interventions to improve safety and effectiveness of medicines. Drugs Real World Outcomes. 2016;3:89–97.CrossRefPubMedCentralGoogle Scholar
- 40.Ollero M, Álvarez M, Barón B. Integrated care process [Pluripathological patients care]. 2nd ed. Andalucia: Andalucian Health Department; 2007.Google Scholar
- 42.WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. WHO. 2012. http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf. Accessed 23 Sept 2017.